RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Janssen-Cilag International N.V🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a2aa1f26a36321b0
Drug Cima Aemps Name: RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211594001
Holder Company Name: Janssen-Cilag International N.V
Marketing Company Name: Janssen Cilag S.A.
Holder Company Detail Path: /organization/janssen-cilag-international-nv
Authorization Date: 2022-01-12
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 50 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Janssen-Cilag International N.V
Company Detail Path: /organization/janssen-cilag-international-nv

AMIVANTAMAB

350 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 12, 2022

Approval ID

a2aa1f26a36321b0

Type

Standard